crovalimab
roche,astrazeneca,novartis,evaluate pharmaceuticals,amgen
['rova,(-approval),(-microvascular)', '$azn', 'evaluatepharma', '$amgn', 'roche,(-broche),(-rocheter)', '$nvs']
#eha2023 roche heads to regulators with its soliris challenger via &amp; #crovalimab #pnh $azn $nvs $amgn $apls
*see story for full chart, consensus forecasts via * 
A fresh view on pharma, medtech and biotech. Sign up to our free daily alert: https://t.co/5OugnsdxXO